A Big Win for Pozen
by Rick Glover
Filed under Arthritis Books
A Big Win for Pozen
We see Vimovo as a $500+ million product in the U.S. alone. Cox-II drugs such as Vioxx and Celebrex, designed to provide safer gastrointestinal profile, peaked sales at over $7 billion worldwide.
Read more on Zacks.com via Yahoo! Finance
